Desalermos A, et al. - In a behavioral weight-management program, researchers assessed a possible connection between obesogenic medication use and insufficient weight loss. The study sample consisted of 666 adult patients in a Veterans Health Administration health system who were part of the MOVE! behavioral weight-loss program. In a behavioral weight-loss program, the use of provider-prescribed obesogenic medications was linked to poorer weight-loss outcomes. Poorer weight-loss outcomes were linked to obesogenic medication use, and patients were 37% less likely to achieve a clinically meaningful (≥ 5% total weight loss) outcome at the end of the MOVE! Program. The greatest difficulty achieving 5% weight loss was seen in patients who received three or more medications vs. the control group. To help improve the outcomes of weight-loss treatments, closer scrutiny of patient medications is needed.